1. Home
  2. HZO vs ANAB Comparison

HZO vs ANAB Comparison

Compare HZO & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

N/A

Current Price

$52.85

Market Cap

1.2B

ML Signal

N/A

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

N/A

Current Price

$46.67

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HZO
ANAB
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
1998
2015

Fundamental Metrics

Financial Performance
Metric
HZO
ANAB
Price
$52.85
$46.67
Analyst Decision
Hold
Strong Buy
Analyst Count
9
8
Target Price
$49.40
★ $87.25
AVG Volume (30 Days)
★ 741.7K
324.4K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
74.13
★ 91.02
EPS
N/A
★ 0.11
Revenue
★ $2,163,989,000.00
$234,603,000.00
Revenue This Year
$5.97
$31.89
Revenue Next Year
$5.80
$65.73
P/E Ratio
★ N/A
$430.55
Revenue Growth
N/A
★ 157.01
52 Week Low
$22.49
$39.02
52 Week High
$52.90
$73.30

Technical Indicators

Market Signals
Indicator
HZO
ANAB
Relative Strength Index (RSI) 67.34 46.22
Support Level $52.23 $44.35
Resistance Level $52.89 $49.16
Average True Range (ATR) 0.08 1.90
MACD -0.03 0.06
Stochastic Oscillator 75.00 43.59

Price Performance

Historical Comparison
HZO
ANAB

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: